Maple City, MI, United States of America

Roger Schofield Newton

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Roger Schofield Newton

Roger Schofield Newton is a notable inventor based in Maple City, Michigan. He has made significant strides in the field of medical treatments, particularly focusing on kidney diseases and fibrosis. With a total of two patents to his name, Newton's work is paving the way for advancements in therapeutic methods.

Latest Patents

Newton's latest patents include the development of functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their derivatives. These inventions are aimed at preventing or treating various diseases, including chronic kidney disease (CKD), kidney fibrosis, heart fibrosis, uterine fibrosis, and cystic fibrosis. The compounds he has developed, represented by various formulae, offer promising methods for addressing these serious health conditions.

Career Highlights

Newton is currently associated with Espervita Therapeutics, Inc., where he continues to innovate and contribute to the field of medical research. His work is characterized by a commitment to improving health outcomes through scientific advancements.

Collaborations

Some of his notable coworkers include Daniela Carmen Oniciu and Gregory R Steinberg. Their collaborative efforts enhance the research environment and foster innovation within the company.

Conclusion

Roger Schofield Newton's contributions to medical science through his patents and work at Espervita Therapeutics, Inc. highlight the importance of innovation in addressing critical health issues. His dedication to developing effective treatments for kidney diseases and fibrosis showcases the potential of scientific research to improve lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…